Ilika Plc Manufacturing agreement for Stereax® with Semefab Ltd

Ilika plc

Ilika plc (LON: IKA), the advanced solid-state battery technology and materials innovation company, announced today an intended manufacturing partnership with Semefab Ltd for the manufacture of Stereaxâ thin film solid-state cells.

Since 1986, Semefab has produced a diverse portfolio of CMOS, ASIC and semiconductor technologies. Ilika and Semefab have undertaken a detailed review of Ilika’s qualified process for the manufacture of Stereaxâ thin film batteries. Semefab has confirmed that it has the microfabrication know-how to be able to manufacture Stereaxâ cells on an economic basis in quantities suitable for market introduction of products. Semefab has also confirmed that the Ilika process is technically compatible with its facility in Fife, Scotland.

Allan James, Semefab Managing Director, stated: “We believe there is a substantial market opportunity for thin-film microfabricated batteries, which is well-aligned with our current business.”

Graeme Purdy, Ilika plc CEO added: “We are delighted to be working with Semefab, which has a long history of manufacturing MEMS and IC products. Semefab is arguably currently the UK’s leading commercial foundry of such devices. This key manufacturing partnership extends Ilika’s market reach and advances the Company one step closer to a valuable licensing deal.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Search